Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study

To control seasonal influenza epidemics in elders, a quadrivalent, inactivated, split-virion influenza vaccine (IIV4) comprising A and B lineages is produced for young individuals and adults aged ≥60 years. In this phase III, randomized, double-blind, active-controlled trial, we compared safety and...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Renfeng, Huang, Xiaoyuan, Nian, Xuanxuan, Ou, Zhiqiang, Zhou, Jian, Zhang, Jiayou, Zeng, Peiyu, Zhao, Wei, Deng, Jinglong, Chen, Wei, Chen, Shaomin, Duan, Kai, Chen, Yingshi, Li, Xinguo, Zhang, Jikai, Yang, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Influenza – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920214/
https://www.ncbi.nlm.nih.gov/pubmed/34473607
http://dx.doi.org/10.1080/21645515.2021.1967041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920214/
https://www.ncbi.nlm.nih.gov/pubmed/34473607
http://dx.doi.org/10.1080/21645515.2021.1967041

Ejemplares similares